Skip to search formSkip to main contentSkip to account menu

Bidil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
In 2005 the FDA approved BiDil, the first drug ever to include a race-specific indication on its label - to treat heart failure… 
2008
2008
June 2007 marked the second anniversary of the Food and Drug Administration (FDA)’s approval of BiDil, the first drug to be… 
Review
2008
Review
2008
In a recent discussion about how scientific knowledge might potentially change our understanding of the nature and extent of… 
2008
2008
Magazine, psychiatrist Sally Satel proudly asserted “I Am a Racial Profiling Doctor.”1 When she treats African Americans in her… 
2007
2007
In 2005, the U.S. Food and Drug Administration (FDA) approved BiDil (NitroMed, Lexington, Massachusetts), a combination of 2… 
Review
2006
Review
2006
This article endeavors to place into context recent developments surrounding the United States Food and Drug Administration… 
2006
2006
On June 23, 2005, the U.S. Food and Drug Administration (FDA) formally approved the heart failure drug BiDil to treat heart… 
2005
2005
Approval of 'race-based' drug is stimulating efforts to detect and predict true subgroups for drug response 
2005
2005
The Food and Drug Administration (FDA) approval of BiDil unleashed a vigorous commentary, mostly critical of the decision. The…